AEON Biopharma, Inc.(AEON)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

AEON Biopharma, Inc. (AEON) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AEON is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 24 institutional filers currently hold this stock. Top institutional holders of AEON by reported 13-F value include Dauntless Investment Group, GEODE CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. AEON trades on the NYSE exchange and files with the SEC under CIK 1837607. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AEON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AEON Biopharma, Inc. directly from SEC EDGAR.